pMCL-HA-MAPKK1-11A55B [S218E/S222D] Citations (3)

Originally described in: Transformation of mammalian cells by constitutively active MAP kinase kinase.
Mansour SJ, Matten WT, Hermann AS, Candia JM, Rong S, Fukasawa K, Vande Woude GF, Ahn NG Science. 1994 Aug 12;265(5174):966-70. PubMed Journal

---

Articles Citing pMCL-HA-MAPKK1-11A55B [S218E/S222D]

Articles
Extracellular signal-regulated kinase activation during cardiac hypertrophy reduces sarcoplasmic/endoplasmic reticulum calcium ATPase 2 (SERCA2) transcription. Huang H, Joseph LC, Gurin MI, Thorp EB, Morrow JP. J Mol Cell Cardiol. 2014 Oct;75:58-63. doi: 10.1016/j.yjmcc.2014.06.018. Epub 2014 Jul 6. PubMed
Activation of the MEK-ERK Pathway Is Necessary but Not Sufficient for Breaking Central B Cell Tolerance. Greaves SA, Peterson JN, Torres RM, Pelanda R. Front Immunol. 2018 Apr 9;9:707. doi: 10.3389/fimmu.2018.00707. eCollection 2018. PubMed
BRAF(V600E)-Driven Lung Tumorigenesis Requires Ligand-Mediated Activation of ERBB Receptor Signaling. Dacheux MA, Wu MJ, Scherzer MT, Nillson M, Murphy B, Schuman S, Ju Z, Bivona T, Lito P, Gumbleton M, Puri S, Akerley W, Wang J, Wang K, Heymach J, Kinsey CG, Negrao M, McMahon M, Vaishnavi A. bioRxiv [Preprint]. 2025 May 9:2025.05.04.652129. doi: 10.1101/2025.05.04.652129. PubMed

If you have published an article using this material, please email us at to have your article added to this page.